Skip to main content
NASDAQ:IPA

ImmunoPrecise Antibodies News Headlines

$7.93
+0.43 (+5.73 %)
(As of 05/14/2021 01:02 PM ET)
Add
Compare
Today's Range
$7.61
$7.94
50-Day Range
$6.80
$12.91
52-Week Range
$2.85
$33.34
Volume1,450 shs
Average Volume105,469 shs
Market Capitalization$152.01 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

ImmunoPrecise Antibodies (NASDAQ IPA) News Headlines Today

SourceHeadline
Short Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Rises By 386.5%Short Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Rises By 386.5%
americanbankingnews.com - April 28 at 1:42 AM
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Up 27.8% in MarchImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Up 27.8% in March
americanbankingnews.com - April 19 at 11:20 AM
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s DiseaseImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease
finance.yahoo.com - April 8 at 8:15 AM
ImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action and Binds all Tested SARS-CoV-2 Variants of ConcernImmunoPrecise Identifies a Unique Antibody, 23-H7, That Demonstrates In Vivo Efficacy, an Alternative Mechanism of Action and Binds all Tested SARS-CoV-2 Variants of Concern
finance.yahoo.com - March 25 at 11:52 AM
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter of 2021 Fiscal YearImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter of 2021 Fiscal Year
finance.yahoo.com - March 17 at 11:10 PM
ImmunoPrecise Announces Participation at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021 (Virtual Conference)ImmunoPrecise Announces Participation at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021 (Virtual Conference)
finance.yahoo.com - March 4 at 10:17 AM
IPAAnnounces Closing of Over-Allotment Option Associated with the Recently CompletedBought Deal Offering of Common SharesIPAAnnounces Closing of Over-Allotment Option Associated with the Recently CompletedBought Deal Offering of Common Shares
marketwatch.com - February 12 at 3:03 AM
IPAAnnounces Closing of $21.7 MillionBought Deal Offering of Common SharesIPAAnnounces Closing of $21.7 MillionBought Deal Offering of Common Shares
marketwatch.com - February 9 at 6:41 AM
IPA Announces Closing of $21.7 Million Bought Deal Offering of Common SharesIPA Announces Closing of $21.7 Million Bought Deal Offering of Common Shares
finance.yahoo.com - February 8 at 5:45 PM
IPA Announces $10.0 Million Bought Deal Offering of Common SharesIPA Announces $10.0 Million Bought Deal Offering of Common Shares
finance.yahoo.com - February 3 at 7:19 PM
If You Had Bought ImmunoPrecise Antibodies (CVE:IPA) Shares Three Years Ago Youd Have Earned 555% ReturnsIf You Had Bought ImmunoPrecise Antibodies (CVE:IPA) Shares Three Years Ago You'd Have Earned 555% Returns
finance.yahoo.com - January 26 at 8:26 AM
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.